Medtronic Total Other Countries Excluding Ireland — Net Sales increased by 0.6% to $8.98B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.7%, from $8.26B to $8.98B. Over 4 years (FY 2021 to FY 2025), Total Other Countries Excluding Ireland — Net Sales shows an upward trend with a 2.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests successful international market expansion and strong global demand for medical devices, while a decrease may indicate regulatory hurdles, competitive pressure, or economic headwinds in foreign markets.
This metric represents the total net revenue generated from all international markets outside of the company's primary c...
Peers in the medical device industry typically report geographic revenue splits; this metric is comparable to 'International Revenue' or 'Revenue outside of North America' reported by global healthcare conglomerates.
mdt_segment_total_other_countries_excluding_ireland_net_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.03B | $7.96B | $7.82B | $7.74B | $7.17B | $7.35B | $7.56B | $7.70B | $7.92B | $7.67B | $7.96B | $8.06B | $8.20B | $7.89B | $8.37B | $8.26B | $9.21B | $8.55B | $8.93B | $8.98B |
| QoQ Change | — | -0.9% | -1.8% | -1.0% | -7.4% | +2.5% | +2.9% | +1.9% | +2.8% | -3.2% | +3.7% | +1.3% | +1.7% | -3.8% | +6.2% | -1.3% | +11.4% | -7.2% | +4.5% | +0.6% |
| YoY Change | — | — | — | — | -10.8% | -7.7% | -3.3% | -0.5% | +10.5% | +4.4% | +5.2% | +4.6% | +3.5% | +2.8% | +5.3% | +2.5% | +12.3% | +8.4% | +6.6% | +8.7% |